Lucid Diagnostics, a New York-based maker of diagnostic tests for esophageal precancer and cancer, filed for a $58 million IPO, per Axios. The pre-revenue company plans to list on the Nasdaq.
Lucid Files for $58M IPO
Related Posts
HHS Awards $16.3M Toward Telehealth for Family Planning
HHS used funds available through the American Rescue Plan to award the money to 31 Title X family planning grantees for a 12-month project period starting May 15
State Hospital Investments Address Shortage of Psych Beds
Several states are collectively putting billions into safety-net hospitals with ties to both the civil and justice systems. At the same time, the private sector struggles to convert demand for services into business opportunities.
PE Firm Colbeck Capital Supports Boston Children’s Hospital
Boston Children’s Hospital has earned accolades as one of the largest pediatric centers in the country along with being named the number one pediatric hospital in the country by U.S. News and World Report.
Mental Health Provider The Collective Hauls in $11M
A year ago, the company disclosed raising $16 million.